Aquagen is a breeding company which develops, produces and delivers genetic material to the global aquaculture industry. AquaGen provides to Regenics unfertilized roe of Atlantic salmon.

AquaGen owns and manages the world's most refined genetic material for Atlantic salmon. Since the 1970s when collecting these fish species began, there has been a continuous research and development in collaboration with industry players and research institutions. Based on a long-term systematic breeding combined with the use of modern breeding technology,  AquaGen offers a unique product.

Contact information:

Postboks 1240, Sluppen
7462 Trondheim



Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.